ABSTRACT OBJECTIVES This study investigated the association between arterial remodeling and geographic distribution of cardiac allograft vasculopathy (CAV), and outcomes after heart transplantation.
Okada et al. 
RESULTS

PATIENT CHARACTERISTICS AND CLINICAL OUTCOMES.
There were a total of 118 consecutive heart trans- Patients with and without late major adverse events showed similar profiles at heart transplantation, except for younger recipient age and lower prevalence of hypertension observed in patients with late major adverse events ( Table 1) . Baseline IVUS indices were also similar, except for a slightly lower intimal volume
at the proximal and distal LAD segments in patients with late major adverse events ( Table 2 ). The triglyceride concentration and use of rapamycin at 1 year post-transplantation were higher in patients with late major adverse events than in those without, whereas the total cholesterol level and use of statins at 1 year
were not significantly different between the 2 groups.
During the first year post-transplantation, 29 patients Values are mean AE SD or %. *One or more episodes of a grade $2R during the first year post-transplant.
Okada et al. Table 3) . This association was preserved in the analysis for cardiac death and retransplantation (n ¼ 15) ( Table 4) . Acute cellular rejection during the first year post-transplantation and 
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/mm). MIT ¼ maximal intimal thickness (mm).
Okada et al. and distribution of CAV after heart transplantation has not been completely elucidated; however, endothelial dysfunction and adventitial inflammation with subsequent fibrosis appear to play important roles, which may not be distributed uniformly over coronary segments after heart transplantation (14,17-19). Okada et al. Previous studies showed the association between acute cellular rejection and CAV progression (12, 13) . In native human vascular disease, aneurysmal lesions typically exhibit greater inflammatory cell Tables 1 and 2. infiltration than do stenotic lesions (22) , although the pathophysiology of this remodeling pattern in
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CAV has yet to be elucidated. wfearon@stanford.edu. 
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